Abstract

Abstract CD10 and MUM1 are representative B cell differentiation markers. Follicular lymphoma (FL) is usually positive for CD10 and negative for MUM1. In this study, however, we compared 22 FLs with peculiar phenotype CD10−MUM1+ with 119 typical CD10+MUM1− FLs. All CD10−MUM1+ FL patients exhibited follicular structure with follicular dendritic meshwork, and a high rate of somatic hypermutation and ongoing mutation, similar to typical FL. However, CD10−MUM1+ FLs were encountered frequently in the elderly compared with CD10+MUM1− typical FLs (67.0 versus 58.7 years, P < .01), showed high grade (grade 3A or 3B) morphology (91% versus 17%, P < .001), diffuse proliferation (59% vs 19%, P < .001), and lacked BCL2/IGH translocation (5% versus 92.5%, P < .001), which is the most characteristic aberration in FL, and 88% showed BCL6 gene abnormalities (translocation or amplification). Our results indicate that CD10−MUM1+ FL is different from typical FL with respect to biologic and clinical features.

Keywords

Follicular lymphomaBCL6Chromosomal translocationBiologyLymphomaPathologySomatic hypermutationInternal medicineCancer researchMedicineGerminal centerGeneB cellImmunologyGeneticsAntibody

Affiliated Institutions

Related Publications

Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies

In situ follicular lymphoma, more recently known as follicular lymphoma-like B cells of uncertain/undetermined significance is well accepted. However, the morphological criteria...

2013 Haematologica 65 citations

Publication Info

Year
2006
Type
article
Volume
109
Issue
7
Pages
3076-3079
Citations
150
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

150
OpenAlex

Cite This

Kennosuke Karube, Ying Guo, Junji Suzumiya et al. (2006). CD10−MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood , 109 (7) , 3076-3079. https://doi.org/10.1182/blood-2006-09-045989

Identifiers

DOI
10.1182/blood-2006-09-045989